Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino
The Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino (CPO-AOU) (Torino, Italy) is active in cancer registration, primary cancer prevention, cancer screening programmes, monitoring the quality of care for cancer patients and research on cancer aetiology, within the Regional Health System. CPO-AOU includes the regional Cancer Registry, one of the first population cancer registries established in Italy. CPO-AOU is recognized among international scientific institutions, collaborating on several international research projects, as can be seen from the large scientific production. Representatives of CPO-AOU are among the Editors of the European Quality Assurance Guidelines for cervical and colorectal cancer, edited in collaboration with International Agency for Research on Cancer (IARC) and funded by the European Commission. CPO-AOU also contributed to the writing of the Quality Assurance Guidelines for breast cancer screening and of the 1st and 2nd Report on the Implementation of Cancer Screening in Europe. In May 2014 CPO-AOU was designated as WHO Collaborative Centre for cancer early detection and screening, representing the only European WHO Collaborative Centre in this field. CPO-AOU is involved in workpackages 2 and 3.
Dr. Livia Giordano
Dr Livia Giordano is Head of the Unit of Epidemiology and Screening –CPO-AOU. She is Member of the Faculty of the Italian School of Senology, member of the School of Public Health, University of Turin, member of the Editorial Board of the journal 'Epidemiologia e Prevenzione' and a member of the Scientific Committee of Europa Donna. She has broad experience in research encompassing epidemiology, cancer screening, smoking cessation and communication strategies. She has also experience in conducting/analysing intervention studies. She has been the president of Gisma (the Italian Group for Breast cancer screening programmes) from 2009 to 2015. Her research fields include Breast and cervical cancer screening organisation and evaluation, randomised trial on cancer screening compliance, communications and psychological aspects in secondary cancer prevention interventions, cancer screening by immigrant and minority women; cancer screening in developing countries and in low-resource settings; smoking prevention and control; cancer screening and healthy lifestyle promotion interventions (diet, physical activity and tobacco consumption).
Dr. Carlo Senore
Dr Carlo Senore has a Master of Science, Epidemiology. He is Coordinator at Piedmont Region screening program and Member of the Regional Coordinating Committee of the Piedmont Region Prevention program. He has expertise in Clinical Trials, Epidemiology, Medical Technology. His research fields include Colorectal and breast cancer screening organisation and evaluation; cancer screening compliance; comparative effectiveness of CRC screening strategies; health technology assessment; guidelines development; smoking prevention and control; cancer screening and healthy lifestyle promotion interventions (diet, physical activity and tobacco consumption). He has experience in design, implementation and analysis of randomized trials evaluating screening strategies, diagnostic technologies and primary prevention interventions, in the development of clinical guidelines and implementation of quality control projects aimed at assessing quality of treatment of colorectal cancer.
Dr. Paola Armaroli
Dr Paola Armaroli is Senior epidemiologist at the Unit of Epidemiology and Screening –CPO-AOU. She is working as MD, Epidemiologist at the Epidemiology Unit and Centre for Cancer Epidemiology and Prevention in the Piedmont Region, CPO-AOU since 2001. She has experience in research encompassing epidemiology and cancer screening. She has been involved in the development of evidence based recommendations and guidelines, specifically as: Member of the Cancer Screening working group, of the Physical activity, body weight, alcohol and breastfeeding working group and of the Literature group in “European Code Against Cancer”; Member of the Literature working group on “EU cervical cancer screening guideline- supplements on HPV testing and HPV vaccination”; Member of the working group on “European guidelines for Quality Assurance of Colorectal Cancer Screening ”. These three projects in collaboration with the International Agency for research on Cancer (IARC) (Lyon, France) and founded by the European Commission.
Dr. Raffaella Rizzolo
Raffaella Rizzolo MSc researcher at the Unit of Epidemiology and Screening –CPO-AOU, has experience in the management and analysis of epidemiological studies, in particular within the multicentre randomised trial on new technologies for cervical cancer screening.
